Company / Free Cash Flow
Catalyst Pharmaceuticals Partners, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$208.6M
FY2025
5-year range
$59.4M / $239.3M
FY2021-FY2025
Trend
-12.8%
vs FY2024
Sector context
#33 of 195
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s free cash flow of $209M is higher than 83% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$26M in FY2018 to $239M in FY2024.
Based on SEC 10-K filings.
$209M in FY2025 with a 5-year CAGR of +35.9%. Top quartile in the Health Care sector.
Improved from $143M to $209M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +35.9%
- 10-Year CAGR
- -
Sector benchmark
-55.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +35.9%, indicating consistent growth.
- In FY2025, free cash flow decreased 12.8% year-over-year.
- Ranks #33 out of 195 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $208.6M | -12.8% |
| FY2024 | $239.3M | +66.9% |
| FY2023 | $143.4M | +23.6% |
| FY2022 | $116.0M | +95.5% |
| FY2021 | $59.4M | +31.8% |
| FY2020 | $45.0M | +30.2% |
| FY2019 | $34.6M | +231.8% |
| FY2018 | -$26.2M | -45.5% |
| FY2017 | -$18.0M | +0.1% |
| FY2016 | -$18.1M | -0.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026